Catalyst Pharmaceutical
CPRX
CPRX
99 hedge funds and large institutions have $169M invested in Catalyst Pharmaceutical in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 22 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 15
0.54% less ownership
Funds ownership: 53.36% → 52.82% (-0.54%)
Holders
99
Holding in Top 10
1
Calls
$293K
Puts
$79K
Top Buyers
| 1 | +$5.3M | |
| 2 | +$4.25M | |
| 3 | +$4.06M | |
| 4 |
CCM
Consonance Capital Management
New York
|
+$3.28M |
| 5 |
Morgan Stanley
New York
|
+$1.74M |
Top Sellers
| 1 | -$6.44M | |
| 2 | -$3.88M | |
| 3 | -$3.22M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$2.37M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$2.24M |